{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:19Z","timestamp":1791313279461,"version":"4.3.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,3,1]]},"DOI":"10.1093\/jac\/47.3.277","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:52:07Z","timestamp":1027723927000},"page":"277-283","source":"Crossref","is-referenced-by-count":81,"title":["Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals"],"prefix":"10.1093","volume":"47","author":[{"given":"F.","family":"Laurent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/47\/3\/277\/9841488\/470277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T07:58:38Z","timestamp":1503475118000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/47.3.277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,1]]},"references-count":0,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1093\/jac\/47.3.277","relation":{},"ISSN":["1460-2091"],"issn-type":[{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,1]]}}}